The use of mechanistic biomarkers for evaluating investigational CNS compounds in early drug development. [electronic resource]
Producer: 20101005Description: 795-801 p. digitalISSN:- 2040-3429
- Animals
- Biomarkers, Pharmacological -- metabolism
- Central Nervous System Agents -- pharmacology
- Clinical Trials, Phase I as Topic -- methods
- Clinical Trials, Phase II as Topic -- methods
- Drug Discovery -- methods
- Humans
- Positron-Emission Tomography -- methods
- Translational Research, Biomedical -- methods
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.